Keurig Dr Pepper Q3 Earnings: Strong Growth Amid Coffee Price Pressures
Keurig Dr Pepper beats Q3 expectations with 11% sales growth to $4.31B, raises full-year outlook to high-single-digits as tariffs drive coffee prices higher.
Keurig Dr Pepper beats Q3 expectations with 11% sales growth to $4.31B, raises full-year outlook to high-single-digits as tariffs drive coffee prices higher.
Novartis acquires Avidity Biosciences for $12 billion, gaining access to breakthrough RNA therapeutics for neuromuscular diseases as the Swiss drugmaker prepares for upcoming patent expirations on key drugs.
Bank of America raises Doximity to Buy with $82 target as pharma companies redirect ad spending from consumers to doctors amid new FDA regulations.
Stifel and Rothschild initiate Buy ratings on Fermi with $29-$31 price targets, citing unique power solutions for AI data centers and attractive growth potential.
Morgan Stanley downgrades Harley-Davidson to Underweight with $25 price target, citing weak pricing power and challenging industry trends that overshadow recovery hopes.
Trump signs trade agreements with Malaysia, Thailand, Vietnam, and Cambodia to reduce tariffs, diversify rare earth supplies, and address trade imbalances as China tightens export controls.